VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q58190368 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000330.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q58190368‏
024 ‎‡a 0000-0003-3471-2535‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q58190368‏
100 0 ‎‡a Maria Joao Baptista‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Maria Joao Baptista‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis‏
670 ‎‡a Author's Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status.‏
670 ‎‡a Author's Epstein-Barr viral loads and serum free light chains levels are potential follow-up markers of HIV-related lymphomas‏
670 ‎‡a Author's Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute‏
670 ‎‡a Author's HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.‏
670 ‎‡a Author's In vitro IL-2 incubation induces CD69 expression and other phenotypic changes on NK subpopulations present in PBPC collections‏
670 ‎‡a Author's Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment‏
670 ‎‡a Author's Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance.‏
670 ‎‡a Author's MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system‏
670 ‎‡a Author's Neoplasms and infections as the main causes of death in patients in complete response to HIV-related non-Hodgkin lymphoma in the combination antiretroviral therapy era: a study out of a series of 146 patients.‏
670 ‎‡a Author's Poly(A) polymerase from Escherichia coli adenylylates the 3'-hydroxyl residue of nucleosides, nucleoside 5'-phosphates and nucleoside(5')oligophospho(5')nucleosides (NpnN).‏
670 ‎‡a Author's Report of the International Splenic Lymphoma Study Group meeting held in 2019 in Barcelona, Spain‏
670 ‎‡a Author's Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma‏
670 ‎‡a Author's ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation‏
909 ‎‡a (orcid) 0000000334712535‏ ‎‡9 1‏
919 ‎‡a differentialgeneexpressionprofileassociatedtoapoptosisinducedbydexamethasoneincllcellsaccordingtoighvzap70status‏ ‎‡A Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status.‏ ‎‡9 1‏
919 ‎‡a analysisoftheighvregioninburkittslymphomassupportsagerminalcenteroriginandaroleforsuperantigensinlymphomagenesis‏ ‎‡A Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis‏ ‎‡9 1‏
919 ‎‡a epsteinbarrviralloadsandserumfreelightchainslevelsarepotentialfollowupmarkersofhivrelatedlymphomas‏ ‎‡A Epstein-Barr viral loads and serum free light chains levels are potential follow-up markers of HIV-related lymphomas‏ ‎‡9 1‏
919 ‎‡a geneticsandepigeneticsofleukemiaandlymphomafromknowledgetoapplicationsmeetingreportofthejosepcarrerasleukaemiaresearchinstitute‏ ‎‡A Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute‏ ‎‡9 1‏
919 ‎‡a hivinfectionimpactonclinicalbiologicalfeaturesandoutcomeofdiffuselargebcelllymphomatreatedwithrchopinthecombinationantiretroviraltherapyera‏ ‎‡A HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.‏ ‎‡9 1‏
919 ‎‡a invitroil2incubationinducescd69expressionandotherphenotypicchangesonnksubpopulationspresentinpbpccollections‏ ‎‡A In vitro IL-2 incubation induces CD69 expression and other phenotypic changes on NK subpopulations present in PBPC collections‏ ‎‡9 1‏
919 ‎‡a inductionofhistoneh12cytosolicreleaseinchroniclymphocyticleukemiacellsaftergenotoxicandnongenotoxictreatment‏ ‎‡A Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment‏ ‎‡9 1‏
919 ‎‡a monosomalkaryotypeinchroniclymphocyticleukemiaassociationwithclinicalandbiologicalfeaturesandpotentialprognosticsignificance‏ ‎‡A Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance.‏ ‎‡9 1‏
919 ‎‡a mycproteinexpressionisassociatedwithpoorprognosisinprimarydiffuselargebcelllymphomaofthecentralnervoussystem‏ ‎‡A MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system‏ ‎‡9 1‏
919 ‎‡a neoplasmsandinfectionsasthemaincausesofdeathinpatientsincompleteresponsetohivrelatednonhodgkinlymphomainthecombinationantiretroviraltherapyeraastudyoutofaseriesof146patients‏ ‎‡A Neoplasms and infections as the main causes of death in patients in complete response to HIV-related non-Hodgkin lymphoma in the combination antiretroviral therapy era: a study out of a series of 146 patients.‏ ‎‡9 1‏
919 ‎‡a polyapolymerasefromescherichiacoliadenylylatesthe3hydroxylresidueofnucleosidesnucleoside5phosphatesandnucleoside5oligophospho5nucleosidesnpnn‏ ‎‡A Poly(A) polymerase from Escherichia coli adenylylates the 3'-hydroxyl residue of nucleosides, nucleoside 5'-phosphates and nucleoside(5')oligophospho(5')nucleosides (NpnN).‏ ‎‡9 1‏
919 ‎‡a reportoftheinternationalspleniclymphomastudygroupmeetingheldin2019inbarcelonaspain‏ ‎‡A Report of the International Splenic Lymphoma Study Group meeting held in 2019 in Barcelona, Spain‏ ‎‡9 1‏
919 ‎‡a usingthelymph2cxassayforassessingcelloforiginsubtypesofhivrelateddiffuselargebcelllymphoma‏ ‎‡A Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma‏ ‎‡9 1‏
919 ‎‡a zap70enhancesmigrationofmalignantblymphocytestowardccl21byinducingccr7expressionviaigmerk12activation‏ ‎‡A ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000070507246
996 ‎‡2 BLBNB|001009581
996 ‎‡2 PTBNP|1918039
996 ‎‡2 SUDOC|076592286
996 ‎‡2 ISNI|0000000040810025
996 ‎‡2 DNB|1060683490
996 ‎‡2 ISNI|000000006658365X
996 ‎‡2 PTBNP|1422950
996 ‎‡2 PTBNP|1691244
996 ‎‡2 DNB|136351808
996 ‎‡2 ISNI|0000000069993048
996 ‎‡2 BLBNB|000311469
996 ‎‡2 ISNI|0000000373516035
996 ‎‡2 LC|no2019117110
996 ‎‡2 ISNI|000000037424123X
996 ‎‡2 PTBNP|899532
996 ‎‡2 NTA|134907523
996 ‎‡2 ISNI|0000000070328926
996 ‎‡2 NUKAT|n 2010149730
996 ‎‡2 PTBNP|7310
996 ‎‡2 PTBNP|7311
996 ‎‡2 NUKAT|n 2007000022
996 ‎‡2 LC|n 98092419
996 ‎‡2 LC|n 95011226
996 ‎‡2 PTBNP|1191485
996 ‎‡2 ISNI|0000000068217469
996 ‎‡2 DNB|1054324859
996 ‎‡2 ISNI|0000000067535617
996 ‎‡2 DNB|131632507
996 ‎‡2 PTBNP|1491826
996 ‎‡2 PTBNP|1193934
996 ‎‡2 PTBNP|115926
996 ‎‡2 PTBNP|7307
996 ‎‡2 SUDOC|125681569
996 ‎‡2 PTBNP|959575
996 ‎‡2 PTBNP|1413485
996 ‎‡2 ISNI|0000000069999415
996 ‎‡2 PTBNP|7306
996 ‎‡2 NKC|jx20100114002
996 ‎‡2 PTBNP|1387203
996 ‎‡2 PTBNP|206117
996 ‎‡2 ISNI|0000000101224207
996 ‎‡2 BLBNB|000542844
996 ‎‡2 PTBNP|263444
996 ‎‡2 ISNI|0000000068785095
996 ‎‡2 ISNI|0000000428418345
996 ‎‡2 ISNI|0000000078455911
996 ‎‡2 ISNI|0000000110492836
996 ‎‡2 PTBNP|7302
996 ‎‡2 PTBNP|1403352
996 ‎‡2 ISNI|0000000428431291
996 ‎‡2 PTBNP|262621
996 ‎‡2 LC|no2002099933
996 ‎‡2 PTBNP|1367464
996 ‎‡2 PTBNP|7309
996 ‎‡2 ISNI|0000000070736348
996 ‎‡2 ISNI|0000000068792121
996 ‎‡2 BLBNB|000608395
996 ‎‡2 PTBNP|1190636
996 ‎‡2 ISNI|0000000070428193
996 ‎‡2 ISNI|0000000020992474
996 ‎‡2 SUDOC|073648892
996 ‎‡2 PTBNP|1419974
996 ‎‡2 ISNI|000000007051012X
996 ‎‡2 ISNI|0000000067882424
996 ‎‡2 PTBNP|7304
996 ‎‡2 PTBNP|972125
996 ‎‡2 LC|n 98910862
996 ‎‡2 ISNI|0000000066651931
996 ‎‡2 PTBNP|1052414
996 ‎‡2 PTBNP|1211010
996 ‎‡2 BLBNB|000564651
996 ‎‡2 BLBNB|001128633
996 ‎‡2 ISNI|0000000069502157
996 ‎‡2 ISNI|0000000070736997
996 ‎‡2 DNB|134143701
996 ‎‡2 SUDOC|280799993
996 ‎‡2 LC|n 84239031
996 ‎‡2 LC|n 89635545
996 ‎‡2 DNB|1056262788
996 ‎‡2 SUDOC|118223925
996 ‎‡2 LC|no2011179417
996 ‎‡2 PTBNP|75627
996 ‎‡2 ISNI|0000000069927817
996 ‎‡2 ISNI|0000000035189342
996 ‎‡2 ISNI|0000000071000455
996 ‎‡2 ISNI|0000000068010628
996 ‎‡2 ISNI|0000000069402682
996 ‎‡2 ISNI|0000000047913852
996 ‎‡2 ISNI|0000000073148154
996 ‎‡2 PTBNP|239312
996 ‎‡2 PTBNP|1109823
996 ‎‡2 PTBNP|1238249
996 ‎‡2 RERO|A012562094
996 ‎‡2 ISNI|0000000069892706
996 ‎‡2 PTBNP|1591236
996 ‎‡2 PTBNP|1854415
996 ‎‡2 PTBNP|1657111
996 ‎‡2 SUDOC|204704057
996 ‎‡2 ISNI|0000000068788181
996 ‎‡2 PTBNP|70675
996 ‎‡2 BLBNB|000199734
996 ‎‡2 LC|no2001087510
996 ‎‡2 BNF|14605875
996 ‎‡2 BLBNB|000678961
996 ‎‡2 PTBNP|794346
996 ‎‡2 PTBNP|123871
996 ‎‡2 BNF|16702137
996 ‎‡2 SUDOC|256795568
996 ‎‡2 BLBNB|000541106
996 ‎‡2 ISNI|000000006811286X
996 ‎‡2 PTBNP|1354328
996 ‎‡2 ISNI|0000000103934237
996 ‎‡2 ISNI|0000000068010847
996 ‎‡2 ISNI|0000000042788300
996 ‎‡2 ISNI|0000000069422296
996 ‎‡2 BIBSYS|7052417
996 ‎‡2 DNB|1056355492
996 ‎‡2 ISNI|0000000066567393
996 ‎‡2 BLBNB|000436375
996 ‎‡2 PTBNP|1567906
996 ‎‡2 PTBNP|493833
996 ‎‡2 ISNI|0000000358938037
996 ‎‡2 LC|n 2022252939
996 ‎‡2 ISNI|0000000070333290
996 ‎‡2 BLBNB|000308619
996 ‎‡2 BNF|12528186
996 ‎‡2 PTBNP|143439
996 ‎‡2 ISNI|0000000431307400
996 ‎‡2 LC|n 97910254
996 ‎‡2 BNCHL|10000000000000000039273
996 ‎‡2 PTBNP|1370442
996 ‎‡2 ISNI|0000000068818600
996 ‎‡2 DNB|1056492562
996 ‎‡2 ISNI|000000011303809X
996 ‎‡2 LC|nb2013009530
996 ‎‡2 PTBNP|1906504
996 ‎‡2 LC|no2001084851
996 ‎‡2 ISNI|0000000067751571
996 ‎‡2 JPG|500690922
996 ‎‡2 PTBNP|1425094
996 ‎‡2 ISNI|0000000068300297
996 ‎‡2 BLBNB|000156670
996 ‎‡2 RERO|A002966765
996 ‎‡2 LC|no 98088100
996 ‎‡2 SUDOC|165440309
996 ‎‡2 DNB|105762778X
996 ‎‡2 BNF|14596026
996 ‎‡2 ISNI|000000006888080X
996 ‎‡2 PTBNP|223770
996 ‎‡2 PTBNP|1303483
996 ‎‡2 ISNI|0000000044785939
996 ‎‡2 PTBNP|1157494
996 ‎‡2 ISNI|0000000068410381
996 ‎‡2 LC|nb2017024653
996 ‎‡2 PTBNP|1155767
996 ‎‡2 ISNI|0000000070438340
996 ‎‡2 ISNI|0000000069487591
996 ‎‡2 PTBNP|1033917
996 ‎‡2 PTBNP|1293150
996 ‎‡2 PTBNP|1382603
996 ‎‡2 BLBNB|001532193
996 ‎‡2 SUDOC|245128573
996 ‎‡2 PTBNP|1252209
996 ‎‡2 ISNI|000000006888689X
996 ‎‡2 BLBNB|000615791
996 ‎‡2 BLBNB|001463387
996 ‎‡2 DNB|1212384172
996 ‎‡2 DNB|1053073747
996 ‎‡2 PTBNP|791847
996 ‎‡2 PTBNP|282452
996 ‎‡2 DNB|105649283X
996 ‎‡2 PTBNP|1356213
996 ‎‡2 LC|n 2007215228
996 ‎‡2 PTBNP|1761130
996 ‎‡2 J9U|987007451229205171
996 ‎‡2 PTBNP|846154
996 ‎‡2 PTBNP|130547
996 ‎‡2 PTBNP|922747
996 ‎‡2 BLBNB|000558653
996 ‎‡2 LC|no2006098673
996 ‎‡2 PTBNP|277022
996 ‎‡2 LC|n 92015955
996 ‎‡2 LC|no2003119289
996 ‎‡2 ISNI|0000000070840110
996 ‎‡2 PTBNP|200425
996 ‎‡2 PTBNP|70981
996 ‎‡2 ISNI|0000000068386828
996 ‎‡2 PTBNP|236618
996 ‎‡2 PTBNP|1772598
996 ‎‡2 ISNI|0000000069928094
996 ‎‡2 PTBNP|1142799
996 ‎‡2 LC|no2004056077
996 ‎‡2 ISNI|0000000066564854
996 ‎‡2 SUDOC|245208364
996 ‎‡2 DNB|130202215
996 ‎‡2 ISNI|0000000068396145
996 ‎‡2 BLBNB|000579111
996 ‎‡2 ISNI|0000000069602211
996 ‎‡2 NTA|142701629
996 ‎‡2 PTBNP|1726025
996 ‎‡2 LC|no 95020192
996 ‎‡2 ISNI|0000000041538406
996 ‎‡2 BNF|15046279
996 ‎‡2 PTBNP|31187
996 ‎‡2 BLBNB|000397464
996 ‎‡2 BIBSYS|98079708
996 ‎‡2 ISNI|0000000437296490
996 ‎‡2 ISNI|0000000428250052
996 ‎‡2 ISNI|0000000070529242
996 ‎‡2 NKC|jo20181009762
996 ‎‡2 SUDOC|081067127
996 ‎‡2 SUDOC|148211240
996 ‎‡2 PTBNP|966319
996 ‎‡2 BLBNB|001576663
996 ‎‡2 BNF|16774913
996 ‎‡2 BLBNB|000565521
996 ‎‡2 NSK|000251503
996 ‎‡2 ISNI|0000000068292127
996 ‎‡2 LC|no2003063152
996 ‎‡2 PTBNP|1109357
996 ‎‡2 BLBNB|000612174
996 ‎‡2 ISNI|0000000069422309
996 ‎‡2 ISNI|0000000069324426
996 ‎‡2 ISNI|0000000069199303
996 ‎‡2 DNB|105706436X
996 ‎‡2 ISNI|0000000094439997
996 ‎‡2 ISNI|0000000077961644
996 ‎‡2 BLBNB|000395462
996 ‎‡2 BLBNB|001454228
996 ‎‡2 PTBNP|799009
996 ‎‡2 DNB|1071961810
996 ‎‡2 ISNI|0000000068006610
996 ‎‡2 ISNI|0000000069413453
996 ‎‡2 ISNI|0000000069789856
996 ‎‡2 PTBNP|1709450
996 ‎‡2 ISNI|0000000070231884
996 ‎‡2 DNB|105337099
996 ‎‡2 ISNI|0000000071001351
996 ‎‡2 ISNI|0000000069932755
996 ‎‡2 LC|no 98093245
996 ‎‡2 ISNI|0000000067677375
996 ‎‡2 PTBNP|109384
996 ‎‡2 ISNI|0000000070610059
996 ‎‡2 DNB|1158672578
996 ‎‡2 ISNI|000000043488967X
996 ‎‡2 BIBSYS|90716839
996 ‎‡2 ISNI|0000000070900718
996 ‎‡2 SELIBR|377863
996 ‎‡2 PTBNP|1899285
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏